Xiamen Zhizi Industry & Trade Co., Ltd. Supplier Evaluation

Executive Summary

Xiamen Zhizi Industry & Trade Co., Ltd. is a China-based supplier located in Fujian, offering plastic medical and sample collection related packaging products such as medical-grade plastic eye dropper bottles, PE eye drop bottles, quick test empty products, and disposable saliva sample collection items. Based on the provided data, the supplier shows a moderate production foundation with a factory area of 5,000+㎡, 50+ staff, and verified supplier status. Its strongest advantage is platform credibility, supported by 22 years as an Gold Supplier, Trade Assurance, finished product inspection, warranty availability, ODM service, and minor customization labels. Business activity is also reasonably solid, with 200+ orders and CN¥2.4M+ transaction value in the past six months. However, the on-time delivery rate of 72.3% is a clear operational risk. This supplier is more suitable for buyers seeking established platform-backed suppliers for medium-volume procurement, with careful attention to delivery control and pre-shipment quality verification.

Detailed Analysis

1. Company Strength

Basis:
- Factory location: Fujian, China
- Factory area: 5,000+㎡
- Staff size: 50+ staff
- Verified supplier / factory audit status: True

Elaboration:
The supplier has a defined factory base and a moderate physical production footprint. A 5,000+㎡ factory and 50+ employees indicate basic to mid-level manufacturing capacity rather than a large-scale industrial operation. The verified supplier status strengthens confidence that the company has passed at least a platform-level supplier verification process. However, no detailed information is provided regarding production lines, annual output, machinery, cleanroom conditions, or formal factory management certifications.

Scoring Rationale:
The company demonstrates more than basic production capability due to its factory size, workforce, and verified supplier status. However, the available data does not support classification as a large-scale supply chain operator because production capacity, equipment details, and factory certifications are not disclosed. Therefore, it fits best within the medium stable factory range, but not at the upper end.

Final Score: 15 / 20

2. Platform & Compliance Credibility

Basis:
- Gold Supplier: True
- Gold Supplier history: 22 years
- Trade Assurance: True
- Certification / industry labels: Warranty available, Finished product inspection, Minor customization, ODM service available
- Verified supplier status: True

Elaboration:
The supplier has a very strong platform credibility profile. A 22-year Gold Supplier history is a significant indicator of long-term platform presence. Trade Assurance provides an additional transaction protection mechanism. The presence of finished product inspection, warranty availability, ODM service, and minor customization labels also improves platform-level credibility. However, no specific external certifications such as ISO, GMP, CE, FDA, or medical device compliance documents are provided in the dataset, so these cannot be assumed.

Scoring Rationale:
This is one of the supplier’s strongest areas. The long Gold Supplier duration, Trade Assurance support, and verified supplier status represent a complete and mature platform trust framework. The score is not a full 20 because formal product or factory compliance certifications are not listed, creating an information gap for regulated medical or healthcare-related procurement.

Final Score: 19 / 20

3. Business Performance

Basis:
- Orders in past six months: 200+
- Transaction value in past six months: CN¥2.4M+
- Store rating: 4.7
- Review count: 40+

Elaboration:
The supplier has demonstrated real transaction activity over the past six months. More than 200 orders and CN¥2.4M+ in transaction value indicate active commercial operations and a certain level of buyer acceptance. The 4.7 store rating is positive, while 40+ reviews provide some customer feedback base, though the review volume is not extremely large.

Scoring Rationale:
The business performance is stable and commercially validated. The supplier shows meaningful recent order volume and transaction value, which reduces the risk of dealing with an inactive or untested seller. However, the review count remains moderate rather than extensive, so the commercial proof is solid but not strong enough to justify a top-tier score.

Final Score: 17 / 20

4. Service Capability

Basis:
- Communication response time: ≤3h
- Customization labels: Minor customization, ODM service available
- Full Customization: Insufficient Data

Elaboration:
The supplier’s response time of within three hours indicates acceptable communication efficiency, though it does not meet the strongest service benchmark of response within one hour. The supplier supports minor customization and ODM service according to platform labels. However, there is no provided evidence of Full Customization capability, dedicated engineering support, multilingual sales teams, or project management structure.

Scoring Rationale:
Service capability appears adequate for standard procurement and limited product adaptation. ODM service is a positive point, but the absence of confirmed Full Customization and the response time being longer than one hour prevent a higher score. The supplier is suitable for buyers with standard or moderately customized requirements rather than complex custom development projects.

Final Score: 7 / 10

5. Delivery Performance

Basis:
- On-time delivery rate: 72.3%

Elaboration:
The supplier’s delivery performance is the weakest area in the available dataset. A 72.3% on-time delivery rate falls within the 70–79% range, indicating that delivery reliability may be inconsistent. For buyers with strict launch schedules, replenishment cycles, or time-sensitive medical packaging procurement, this figure requires close attention.

Scoring Rationale:
According to the scoring framework, a 70–79% on-time delivery rate corresponds to 5–6 points. Given that 72.3% is close to the lower side of this bracket, the supplier receives a conservative score. Delivery risk should be actively managed through confirmed lead times, production milestones, shipment buffers, and contractual delivery terms.

Final Score: 5 / 10

6. Quality & Customer Feedback

Basis:
- Store rating: 4.7
- Review count: 40+
- Finished product inspection: Present
- Verified supplier / factory audit status: True
- Warranty available: Present

Elaboration:
The supplier has a positive store rating and a moderate number of reviews, indicating generally favorable customer feedback. Finished product inspection and warranty availability add quality assurance support at the platform level. Verified supplier status further supports basic confidence in the supplier’s operational legitimacy. However, no detailed inspection reports, defect rates, complaint history, product testing documents, or formal quality certifications are provided.

Scoring Rationale:
The quality profile is good but not fully comprehensive. The 4.7 rating and finished product inspection label support a positive assessment, while the moderate review count and lack of specific quality certifications prevent a top-tier score. For products described as medical-grade or sample collection related, buyers should request additional compliance and inspection documentation before placing large or regulated orders.

Final Score: 16 / 20

Total Score

Total Score: 79 / 100

• Company Strength: 15 / 20
• Platform & Compliance Credibility: 19 / 20
• Business Performance: 17 / 20
• Service Capability: 7 / 10
• Delivery Performance: 5 / 10
• Quality & Customer Feedback: 16 / 20

Procurement Recommendation

Cooperation is recommended with conditions. Xiamen Zhizi Industry & Trade Co., Ltd. is suitable for buyers seeking an established supplier with long platform history, Trade Assurance support, moderate production capacity, and verified transaction performance. It is especially appropriate for medium-volume buyers requiring eye dropper bottles, plastic sample collection packaging, or similar listed products.

The main risk is delivery reliability, as the 72.3% on-time shipment rate is below strong supplier standards. Additional risks include insufficient data on formal medical-grade certifications, detailed factory certifications, production capacity, and full customization capability. Buyers should request product compliance documents, inspection reports, samples, confirmed lead times, and written delivery commitments before bulk orders.

The supplier’s growth potential is supported by long-term platform presence, ODM availability, finished product inspection, and active recent transaction performance, but operational delivery control should be improved before it can be considered a stronger strategic supplier.